Photo: airdone / iStock / Getty Images
Virginia is set to receive up to $16.4 million from a major $720 million nationwide settlement with eight generic drug companies accused of contributing to the opioid epidemic. Attorney General Jason Miyares announced the deal on Thursday, calling it a step toward justice for the communities harmed by the widespread distribution of addictive painkillers.
“These companies treated Virginians like lab rats, pushing dangerous drugs for profit,” Miyares said. “While no amount of money can undo the damage, this funding will help our communities recover and hold these corporations responsible.”
The settlement involves companies like Mylan (now part of Viatris), Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus. Mylan is paying the largest share—over $284 million spread over nine years. Other contributions include $95 million from Hikma, $71 million from Amneal, and $63 million from Apotex. Some companies will make lump-sum payments, while others will contribute over time.
SOURCE: WHSV3